tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRNX Stock Latest News

Crinetics randomizes first patient in CAREFNDR trial
The FlyCrinetics randomizes first patient in CAREFNDR trial
8d ago
CRNX
Buy Rating Justified by Strategic Initiatives and Growth Prospects at Crinetics Pharmaceuticals
PremiumRatings
Buy Rating Justified by Strategic Initiatives and Growth Prospects at Crinetics Pharmaceuticals
18d ago
CRNX
Crinetics price target raised to $45 from $40 at Goldman Sachs
PremiumThe Fly
Crinetics price target raised to $45 from $40 at Goldman Sachs
19d ago
CRNX
Crinetics Pharma’s Positive Earnings Call Highlights PALSONIFY Success
PremiumCompany Announcements
Crinetics Pharma’s Positive Earnings Call Highlights PALSONIFY Success
20d ago
CRNX
Crinetics Pharmaceuticals: Strong Market Entry and Financial Position Support Buy Rating
PremiumRatings
Crinetics Pharmaceuticals: Strong Market Entry and Financial Position Support Buy Rating
22d ago
CRNX
Crinetics price target lowered to $108 from $143 at Citizens JMP
PremiumThe FlyCrinetics price target lowered to $108 from $143 at Citizens JMP
22d ago
CRNX
Crinetics Pharmaceuticals Reports Positive Launch and Financials
Premium
Company Announcements
Crinetics Pharmaceuticals Reports Positive Launch and Financials
22d ago
CRNX
Crinetics reports Q3 EPS ($1.38), consensus ($1.25)
Premium
The Fly
Crinetics reports Q3 EPS ($1.38), consensus ($1.25)
22d ago
CRNX
Crinetics Pharmaceuticals: Promising PFS Data and Strategic Focus Justify Buy Rating
PremiumRatings
Crinetics Pharmaceuticals: Promising PFS Data and Strategic Focus Justify Buy Rating
1M ago
CRNX
Crinetics Pharma’s Atumelnant Study: A Promising Phase 1 Update
PremiumCompany Announcements
Crinetics Pharma’s Atumelnant Study: A Promising Phase 1 Update
1M ago
CRNX
Crinetics Pharma’s Paltusotine Study: A Potential Game-Changer for Carcinoid Syndrome
PremiumCompany Announcements
Crinetics Pharma’s Paltusotine Study: A Potential Game-Changer for Carcinoid Syndrome
1M ago
CRNX
Crinetics Pharma’s CRN09682 Study: A Potential Breakthrough in Tumor Treatment
PremiumCompany Announcements
Crinetics Pharma’s CRN09682 Study: A Potential Breakthrough in Tumor Treatment
1M ago
CRNX
Crinetics Pharma’s Promising Extension Study on Atumelnant: A Potential Game-Changer for Adrenal Disorders
PremiumCompany AnnouncementsCrinetics Pharma’s Promising Extension Study on Atumelnant: A Potential Game-Changer for Adrenal Disorders
1M ago
CRNX
Crinetics Pharma’s New Study on Atumelnant: A Potential Game-Changer for CAH Treatment
Premium
Company Announcements
Crinetics Pharma’s New Study on Atumelnant: A Potential Game-Changer for CAH Treatment
1M ago
CRNX
Crinetics Pharma’s Promising Study on Atumelnant for Pediatric CAH
Premium
Company Announcements
Crinetics Pharma’s Promising Study on Atumelnant for Pediatric CAH
1M ago
CRNX
Crinetics Pharma’s Promising Study on CRN04894 for Cushing’s Syndrome: A Potential Game-Changer?
PremiumCompany Announcements
Crinetics Pharma’s Promising Study on CRN04894 for Cushing’s Syndrome: A Potential Game-Changer?
1M ago
CRNX
3 Best Stocks to Buy Now, 10/27/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/27/2025, According to Top Analysts
1M ago
WAY
CRNX
Promising Phase 3 Data and Strong Financial Position Justify Buy Rating for Crinetics Pharmaceuticals
PremiumRatings
Promising Phase 3 Data and Strong Financial Position Justify Buy Rating for Crinetics Pharmaceuticals
1M ago
CRNX
Crinetics to highlight neuroendocrine tumor research progress at NANETS 2025
PremiumThe Fly
Crinetics to highlight neuroendocrine tumor research progress at NANETS 2025
1M ago
CRNX
Positive Long-Term Growth Outlook for Crinetics Pharmaceuticals Amid Palsonify Approval
PremiumRatingsPositive Long-Term Growth Outlook for Crinetics Pharmaceuticals Amid Palsonify Approval
1M ago
CRNX
3 Must-See Stocks with Strong-Buy Ratings and a Perfect 10 Score
Premium
Market News
3 Must-See Stocks with Strong-Buy Ratings and a Perfect 10 Score
2M ago
PGY
CRNX
Crinetics price target raised to $87 from $73 at Oppenheimer
Premium
The Fly
Crinetics price target raised to $87 from $73 at Oppenheimer
2M ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >